To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Glucosamine sulfate ineffective for chronic low back pain and degenerative lumbar OA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
July 2013

Glucosamine sulfate ineffective for chronic low back pain and degenerative lumbar OA

Vol: 2| Issue: 6| Number:69| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial

JAMA. 2010 Jul 7;304(1):45-52.

Contributing Authors:
P Wilkens IB Scheel O Grundnes C Hellum K Storheim

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

250 patients (>25 yr) with chronic LBP(>6 month) and degenerative lumbar osteoarthritis(OA) were randomized to be administered 1500mg per day of glucosamine or placebo for 6 months duration. At 12 month time point, glucosamine sulfate was deemed ineffective in treating chronic LBP and other symptoms of degenerative lumbar osteoarthritis.

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.

Continue